Elevated serum progesterone level on the day of human chorionic gonadotropin administration does not adversely affect implantation rates after intracytoplasmic sperm injection and embryo transfer

Fertility and Sterility

Volumn 72, Issue 6, 1999, Pages 975-979

  Urman, Bulent ^a   Alatas, Cengiz ^a   Aksoy, Senai ^a   Mercan, Ramazan ^a   Isiklar, Aycan ^a   Balaban, Basak ^a  

^a AMERICAN HOSPITAL   (Turkey)

Author keywords

Fertilization in vitro; Implantation; Intracytoplasmic sperm injection; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN;

ABORTION; ARTICLE; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADULT; CHORIONIC GONADOTROPIN; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY RATE; PREGNANCY, HIGH-RISK; PROGESTERONE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032704748     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00421-5     Document Type: Article

References (19)

1. Edelstein M., Seltman H., Cox B., Robinson S., Shaw R., Muasher S. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril. 54:1990;853-857.
2. Silverberg K., Burns W., Olive D., Riehl R., Schenken R. Serum progesterone levels predict success of in vitro fertilization embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab. 73:1991;797-803.
3. Prien S., Canez M., Messer R. Increases in progesterone following human chorionic gonadotropin administration may predict cycle outcome in patients undergoing in vitro fertilization and embryo transfer. Fertil Steril. 62:1994;1066-1068.
4. Givens C., Schirock E., Dandekar P., Martin M. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril. 62:1994;1011-1017.
5. Dumesic D. Periovulatory serum progesterone levels as a predictor of pregnancy outcome during ovarian hyperstimulation for assisted reproductive technology. Fertil Steril. 62:1994;911-912.
6. Bustillo M., Stern J., Coulam C. Serum progesterone at the time of human chorionic gonadotropin does not predict pregnancy in in-vitro fertilization and embryo transfer. Hum Reprod. 11:1995;2862-2867.
7. Levy M., Smotrich D., Widra E., Sagoskin A., Murray D., Hall J. The predictive value of serum progesterone levels on in vitro fertilization outcome. J Assist Reprod Genet. 12:1995;161-166.
8. Abuzeid M., Sasy M. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril. 65:1996;981-985.
9. Hofmann G., Khoury J., Johnson J., Thie J., Scott R. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril. 66:1996;980-986.
10. Moffitt D., Queenan J., Shaw R., Muasher S. Progesterone levels on the day of human chorionic gonadotropin do not predict pregnancy outcome from the transfer of fresh or cryopreserved embryos from the same cohort. Fertil Steril. 67:1997;296-301.
11. Ubaldi F., Camus M., Smitz J., Bennink H., Van Steirteghem A., Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropin releasing hormone agonist (GnRH-a) and recombinant follicle stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril. 66:1996;275-280.
12. Huang J.C., Jackson K.V., Hornstein M.D., Ginsburg E.S. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization and embryo transfer. J Assist Reprod Genet. 13:1996;617-624.
13. Fanchin R., Righini C., Olivennes F., de Ziegler D., Selva J., Frydman R. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril. 65:1996;1178-1183.
14. Ezra Y., Simon A., Sherman Y., Benshushan A., Younis J., Laufer N. The effect of progesterone administration in the follicular phase of an artificial cycle on endometrial morphology a model of premature luteinization . Fertil Steril. 62:1994;108-112.
15. Hofmann G.E., Bentzien F., Bergh P.A., Garissi G.J., Williams M.C., Guzman I., et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 60:1993;675-679.
16. Ubaldi F., Smitz J., Wisanto A., Joris H., Schiettecatta J., Derde M.P., et al. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod. 10:1995;3091-3096.
17. Burns W., Witz C., Klein N., Silverberg K., Schenken R. Serum progesterone concentrations on the day after human chorionic administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome. J Assist Reprod Genet. 11:1994;17-23.
18. Urman B., Pride S., Ho Yuen B. Management of overstimulated gonadotrophin cycles with a controlled drift period. Hum Reprod. 7:1992;213-217.
19. Benadiva C, Moomjy M, Kligman I, Liu H, Davis O, Rosenwaks Z. Withholding gonadotropin administration is an effective alternative to cryopreservation of all embryos for the prevention of ovarian hyperstimulation syndrome (OHSS). [Abstract no. P-245]. In: Fifty-First Annual Meeting of the American Society for Reproductive Medicine, Seattle, WA. 1995;205-6.